Encapsulated Neoplasm — Trials

Encapsulated Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

60 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03753919	Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial(DUTHY)	terminated	Phase 2	79	Grupo Espanol de Tumores NeuroendocrinosOTHER	1	Mar 11, 2026	clinicaltrials
NCT03506048	Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer	terminated	Phase 2	4	Emory UniversityOTHER	1	Nov 10, 2022	clinicaltrials
NCT03630120	Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer	terminated	Phase 2	6	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Jul 14, 2021	clinicaltrials
NCT00095693

Data updated 22 days agoSource updated Mar 11, 2026source: clinicaltrials